AbbVie Inc. is 381.0x more valuable than Savara Inc by market capitalization ($397.44 B vs $1.04 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SVRA | ABBV |
|---|---|---|
| Market cap | $1.04 B | $397.44 B |
| US-listed rank | #2602 | #28 |
| Revenue (latest FY) | $257.00K | $61.16B |
| Net income (latest FY) | -$118.84M | $4.23B |
| Net margin | -46240.1% | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 1,331 | 1,008 |
AbbVie Inc. is 381.0x more valuable than Savara Inc by market capitalization ($397.44 B vs $1.04 B).
Full pages: Savara Inc and AbbVie Inc., or browse the full rankings.